At first prescription, the prescriber/healthcare professional (HCP) should discuss with the patient the risks described within the discussion guide. The guide is aimed at increasing awareness about the potential risk of haematological effects and liver effects, risk of hypertension, serious infections and teratogenicity with teriflunomide and providing guidance on how to manage that risk. For hard copies of this information, please contact axunio Pharma via email to [email protected].

${pdf_link}$

Teriflunomide Patient Card

This patient card provides important information on the risks of teriflunomide. At first prescription, the prescriber should provide this card. Please show this card to any doctor or healthcare professional involved in your medical care (e.g., in case of an emergency). For hard copies, please contact axunio Pharma via email to [email protected].

Dr. Reddy's Laboratories (UK) Ltd

${pdf_link}$

Dr. Reddy's Teriflunomide Alert Card

Patient Alert Card

${pdf_link}$

Dr. Reddy's Teriflunomide HCP Guide

HEALTHCARE PROFESSIONAL EDUCATION/DISCUSSION GUIDE.

MSN Laboratories Europe Ltd

${pdf_link}$

Healthcare Professional Education/Discussion Guide - Teriflunomide

HCP guide

${pdf_link}$

Patient Alert Card Teriflunomide

Patient alert card

Mylan

${pdf_link}$

TERIFLUNOMIDE MYLAN HEALTHCARE PROFESSIONAL EDUCATION/DISCUSSION GUIDE

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

${pdf_link}$

TERIFLUNOMIDE MYLAN PATIENT CARD

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Sandoz Limited

${pdf_link}$

Teriflunomide Sandoz 14 mg Film-coated Tablets - Healthcare Professional Guide

Provides guidance to HCPs on the risks associated with teriflunomide and explains that patients should be regularly consulted about these risks. Potential risks are described as are monitoring methods. Risk of teratogenicity is described and that teriflunomide is contraindicated in pregnancy. Specific guidance on this subject is also offered.

${pdf_link}$

Teriflunomide Sandoz 14mg Film-coated Tablets - Patient Alert Card

This patient alert card provides important information to patients, on the risks of using teriflunomide. This includes a warning that teriflunomide should not be used during pregnancy and offers further guidance on this subject to women who are using teriflunomide.

Risk Minimisation Materials

Aubagio

SANOFI

Teriflunomide

Amarox Limited

axunio Pharma GmbH

Dr. Reddy's Laboratories (UK) Ltd

MSN Laboratories Europe Ltd

Mylan

Sandoz Limited

You are trying to reach document intended for healthcare professionals only.